Chief Scientific Advisors Update on...

Susan G. Komen chief scientific advisors discuss COVID-19's impact on breast cancer research....

Dr. Elizabeth Mittendorf Wants To...

Dr. Elizabeth Mittendorf is working to see if a breast cancer patient’s immune system can be taught to recognize tumors,......

Maintaining Commitment to Breast Cancer...

Even though COVID-19 has disrupted research and laboratories across the US, Komen's commitment to funding breakthrough research has not changed....

Dr. Nadine Tung Discusses Surprising...

Dr. Nadine Tung led a clinical trial to determine if there was a better treatment option for breast cancer patients......

Everyone Can Take Action on...

October is not just about making people aware of metastatic breast cancer, it is about taking action to improve their......

Control Your Data; Direct Your...

By controlling their health data, patients can direct their healthcare....

In Case You Missed It:...

Susan G. Komen's David Vaught tells us why vaccines are important for the flu, COVID-19 and breast cancer....

Wolff Emphasizes the Value of...

Dr. Antonio Wolff, M.D., recently talked with Susan G. Komen about the importance of including loved ones in patients’ care.......

FDA’s New Guidance Recommends Including...

New federal guidance recommends that breast cancer clinical trials be open to men – who are being diagnosed with and......

Dr. Daniel Stover Leverages Lab...

Dr. Daniel Stover has improved his patients' care through lessons he's learned in the lab....

Sheila McGlown Offers Advice for...

Sheila McGlown is on a clinical trial for her metastatic breast cancer. She shares ways to increase participation in trials,......

For Komen Scholar Barbara Segarra-Vazquez,...

Dr. Barbara Segarra-Vazquez shares ideas for including more patient perspectives in breast cancer research and treatment....